Non-invasive biomarker monitoring startup lands more funding
Liom boasts miniaturization breakthrough in spectroscopy-powered continuous glucose monitoring technology. Swiss healthtech startup Liom has secured a $16.5 million…
Liom boasts miniaturization breakthrough in spectroscopy-powered continuous glucose monitoring technology. Swiss healthtech startup Liom has secured a $16.5 million…
Schwyz-based Liom, an innovator in non-invasive biomarker monitoring and the developer of a non-invasive glucose-monitoring wearable, announced a €13.9 million…